EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoantibodies in Atrial Fibrillation—State of the Art

Joanna Zygadło iD, Grzegorz Procyk iD, Paweł Balsam, Piotr Lodziński iD, Marcin Grabowski, Aleksandra Gąsecka iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24031852 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Joanna Zygadło und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. To date, a lot of research has been conducted to investigate the underlying mechanisms of this disease at both molecular and cellular levels. There is increasing evidence suggesting that autoimmunity is an important factor in the initiation and perpetuation of AF. Autoantibodies are thought to play a pivotal role in the regulation of heart rhythm and the conduction system and, therefore, are associated with AF development. In this review, we have summarized current knowledge concerning the role of autoantibodies in AF development as well as their prognostic and predictive value in this disease. The establishment of the autoantibody profile of separate AF patient groups may appear to be crucial in terms of developing novel treatment approaches for those patients; however, the exact role of various autoantibodies in AF is still a matter of ongoing debate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHumansAutoantibodiesHeart Conduction SystemAutoimmunityCardiac Conduction System Disease

Stichwörter der Autor:innen

arrhythmiasatrial fibrillationautoantibodiesautoimmunization

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
  • Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.

ORCID-Profile: Joanna Zygadło, Grzegorz Procyk, Piotr Lodziński, Aleksandra Gąsecka

Zitieren

APA

Zygadło, J., Procyk, G., Balsam, P., Lodziński, P., Grabowski, M., & Gąsecka, A. (2023). Autoantibodies in Atrial Fibrillation—State of the Art. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24031852

Vancouver

Zygadło J, Procyk G, Balsam P, Lodziński P, Grabowski M, Gąsecka A. Autoantibodies in Atrial Fibrillation—State of the Art. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24031852

BibTeX
@article{Zygado2023,
  author = {Zygadło, Joanna and Procyk, Grzegorz and Balsam, Paweł and Lodziński, Piotr and Grabowski, Marcin and Gąsecka, Aleksandra},
  title = {Autoantibodies in Atrial Fibrillation—State of the Art},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24031852}
}
Kostenlos starten →